Vanda Pharmaceuticals, Inc. (VNDA)

[lecorb]

Now I understand the new analyst target $ 6


These are the funds that bought in March 2014

FMR 4.52M $73.37M March 31, 2014
Baker Bros. Advisors 4.45M $72.24M March 31, 2014
Palo Alto Investors 3.22M $52.25M March 31, 2014
Kingdon Capital Management 1.91M $31.08M March 31, 2014
T. Rowe Price Associates 1.75M $28.47M March 31, 2014
STATE STREET CORPORATION 1.55M $25.26M March 31, 2014
GOLDMAN SACHS 1.53M $24.91M March 31, 2014
Inves 1.48M $24.12M March 31, 2014
Paulson & Co 1.39M $22.63M March 31, 2014
SUSQUEHANNA INTERNATIONAL 1.35M $21.92M March 31, 2014
BlackRock Fund Advisors 1.34M $21.71M March 31, 2014
Consonance Capital 1.23M $19.94M March 31, 2014
BVF 1.14M $4.45M March 31, 2013
BlackRock Institutional Trust Company, N.A. 1.08M $17.55M March 31, 2014
Vanguard 1.00M $16.30M March 31, 2014
WALL STREET ASSOCIATES 705100 $11.46M March 31, 2014
BOGLE INVESTMENT MANAGEMENT L P /DE/ 606489 $9.86M March 31, 2014

A total of 22.41 million shares more ( DILUTION)

Average Purchase $ 331,910,000

Average total purchase: $14.81

Now you understand, why they want that you buy?

Besides dilution want to steal. Less

Now I understand analysts TDA
ResearchTeamTM Sell
TheStreet:Sell
S&P Capital IQ:No rating
Ford Equity Research: Strong Sell
MarketEdge:No rating
Jaywalk Consensus:Sell

Now one understands these ratings!